PDCD1LG2 and melanoma: On the other hand, PD-L2 expression was observed in melanoma, non–small cell lung cancer, head and neck squamous cell carcinoma, triple-negative breast cancer, and renal, bladder, or gastric cancer, and can also occur in the absence of PD-L1 [26].